Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison.
Am J Hematol
; 92(8): E146-E152, 2017 Aug.
Article
en En
| MEDLINE
| ID: mdl-28474745
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Anticuerpos Monoclonales
/
Mieloma Múltiple
/
Antineoplásicos
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2017
Tipo del documento:
Article